Correlation Between Cyteir Therapeutics and Histogen
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and Histogen, you can compare the effects of market volatilities on Cyteir Therapeutics and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and Histogen.
Diversification Opportunities for Cyteir Therapeutics and Histogen
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cyteir and Histogen is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and Histogen go up and down completely randomly.
Pair Corralation between Cyteir Therapeutics and Histogen
If you would invest 276.00 in Cyteir Therapeutics on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Cyteir Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 4.55% |
Values | Daily Returns |
Cyteir Therapeutics vs. Histogen
Performance |
Timeline |
Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Histogen |
Cyteir Therapeutics and Histogen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cyteir Therapeutics and Histogen
The main advantage of trading using opposite Cyteir Therapeutics and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Histogen vs. PayPal Holdings | Histogen vs. Nasdaq Inc | Histogen vs. Choice Hotels International | Histogen vs. Microsoft |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stocks Directory Find actively traded stocks across global markets |